Month: November 2018

What to Expect at a Scientific Conference

I recently had the privilege of attending a small rare disease conference in Vienna, Austria. I have been to several other conferences, but nevertheless I found myself wondering what exactly to expect from this one. When I was in graduate school getting my PhD, I found that I frequently asked…

Small Molecule Drug Discovery

This week’s topic focuses on a narrower area of biotech/pharma early drug discovery. Most approved drugs are small molecules. Classically, these drugs abide by Lipinski’s Rule of 5. However, many final drug candidates that enter the clinic do not exactly follow these rules. One may make the obvious assertion here…

Biotech Options Trading

When people think of investing, they think of buying and selling individual stocks, mutual funds, index funds, ETFs, bonds, etc. And I will say right off the bat, that the vast majority of investors, especially in biotech, are better off with these more standard trading strategies than options trading. The…